|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 人类血压测量方法:美国心脏协会科学声明显示文摘准确的血压测量对高血压诊断与治疗至关重要。该文是美国心脏协会关于人类血压测量的最新科学声明。业已证实,在诊室许多电子血压计可以准确测量血压,同时减少与听诊法有关的人为误差。即使没有一个观察者在场,全自动电子血压计也可以通过多次测量提供较听诊法更准确的血压测量值。研究表明诊室外所测血压与诊室血压比较存在实质性差别。目前认为动态血压监测是诊室外血压评估的参考标准,当动态血压监测不可行或患者不能耐受时,家庭血压监测则是一个替代方法。 | 赵狄(摘译) 练桂丽(审校) Muntner P Shimbo D Carey RM Charleston JB Gaillard T Misra S Myers MG Ogedegbe G Schwartz JE Townsend RR Urbina EM Viera AJ White WB Wright JT Jr | 2019 | 中华高血压杂志2019,27,6: | 16 |
| 2 | Four-year follow-up of endoscopic gastroplication for the treatment of gastroesophageal reflux disease显示文摘AIM:To evaluate the long-term effect of Endocinch treatment for gastroesophageal reflux disease(GERD).METHODS:After unblinding and crossover,50 patients(32 males,18 females; mean age 46 years) with pH-proven chronic GERD were recruited from an initial randomized,placebo-controlled,single-center study,and included in the present prospective open-label follow-up study.Initially,three gastroplications using the Endocinch device were placed under deep sedation in a standardized manner.Optional retreatment was offered in the first year with 1 or 2 extra gastroplications.At baseline,3 mo after(re) treatment and yearly proton pump inhibitor(PPI) use,GERD symptoms,quality of life(QoL) scores,adverse events and treatment failures(defined as:patients using > 50% of their baseline PPI dose or receiving alternative antireflux therapy) were assessed.Intention-to-treat analysis was performed.RESULTS:Median follow-up was 48 mo [interquartile range(IQR):38-52].Three patients were lost to follow-up.In 44% of patients retreatment was done after a median of 4 mo(IQR:3-8).No serious adverse events occurred.At the end of follow-up,symptom scores and4 out of 6 QoL subscales were improved(all P < 0.01compared to baseline).However,80% of patients required PPIs for their GERD symptoms.Ultimately,64% of patients were classified as treatment failures.In 60% a post-procedural endoscopy was carried out,of which in 16% reflux esophagitis was diagnosed.CONCLUSION:In the 4-year follow-up period,the subset of GERD patients that benefit from endoscopic gastroplication kept declining gradually,nearly half opted for retreatment and 80% required PPIs eventually. | Matthijs P Schwartz J Rieneke C Schreinemakers André J P M Smout | 2013 | World Journal of Gastrointestinal Pharmacology and Therapeutics2013,4,4: | 4 |
| 3 | C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease显示文摘AIM: To explore if C-reactive protein (CRP) levels might serve as a prognostic factor with respect to the clinical course of Crohn's disease and might be useful for classification.METHODS: In this retrospective cohort study we enrolled 94 patients from the inflammatory bowel disease (IBD) database of the University Medical Centre Utrecht. CRP levels during relapse were correlated with the number of relapses per year. Severity of relapses was based on endoscopic reports and prednisone use. Furthermore, patients were categorized in a low or high CRP group based on their CRP response during relapse and demographic and clinical features were compared.RESULTS: Overall, a positive correlation between CRP levels, number of relapses, and severity of relapse was found (respectively rs = 0.31, P < 0.01 and rs = 0.50, P < 0.001). Employing a cut-off level of 15 mg/L, the index CRP level was found to discriminate patients with respect to the number of relapses per year, as well as for severity of relapses (respectively 0.25 ± 0.16 vs 0.36 ± 0.24, P < 0.05 and 4.4 ± 1.2 vs 3.2 ± 1.1 on a 10-point visual analogue scale, P < 0.001 for the high CRP and low CRP groups respectively). In addition, the high CRP group showed more cumulative days of prednisone use per year (107 ± 95 vs 58 ± 48, P < 0.05), as well as a better response to infliximab (93 % vs 33 %, P = 0.06).CONCLUSION: A higher CRP level during relapse seems to be associated with a more severe clinical course of disease. | Chantal L Koelewijn Matthijs P Schwartz Melvin Samsom Bas Oldenburg | 2008 | World Journal of Gastroenterology2008,14,1: | 4 |
| 4 | Subepicardial endothelial cells invade the embryonic ventricle wall to form coronary arteries显示文摘冠的动脉把血流动带到心肌肉。理解冠的动脉的发展程序提供卓见进冠的动脉疾病的治疗。多重来源被描述了为包括 proepicardium,湾穴 venosus (SV ) ,和心内膜贡献冠的动脉。然而,冠的容器的发展起源仍然在强烈学习下面。我们为学习冠的开发生产了一个新基因工具,一只 AplnCreER 老鼠在开发冠的容器明确地衬里 recombinase,它表示可诱导的 Cre。冠的开发和 AplnCreER 命运跟踪的预定正式就职的定量分析证明 subepicardial endothelial 房间(EC ) 的子孙两个都入侵紧缩的心肌层形成冠的动脉并且在表面上留下生产静脉。我们发现这些 subepicardial EC 是 intramyocardial 的主要来源在发展中的心的冠的容器。在 vitro 将生物的活组织移植于培养基中培养,试金显示这些 subepicardial EC 的多数从 SV 和中庭的心内膜,然而并非从室的心内膜产生。Apln 积极的房间的同种细胞的分析显示单个 subepicardial EC 同等地作出贡献到冠的动脉和静脉。一起,这些数据建议 subepicardial EC 是 intramyocardial 的主要来源在室的冠的动脉墙,和那冠的动脉和静脉在发展中的心有普通起源。 | Xueying Tian Tianyuan Hu Hui Zhang Lingjuan He Xiuzhen Huang Qiaozhen Liu Wei Yu Liang He Zhongzhou Yang Zhen Zhang Tao P Zhong Xiao Yang Zhen Yang Yan Yan Antonio Baldini Yunfu Sun Jie Lu Robert J Schwartz Sylvia M Evans Adriana C Gittenberger-de Groot Kristy Red-Horse Bin Zhou | 2013 | Cell Research2013,23,9: | 3 |
| 5 | Ein gezielter aufbau des chlorinsystems显示文摘 | Montforts F P Schwartz U M | 1985 | Liebigs Ann Chem1985,,: | 2 |
| 6 | Totalsynthese yon ( + / - ) bonellindimethylester显示文摘 | Montforts F P Schwartz U M | 1991 | Liebigs Ann Chem1991,,: | 2 |
| 7 | Volumetric Analysis Predicts Hepatic Dysfunction in Patients Undergoing Major Liver Resection显示文摘 | Margo Shoup Mithat Gonen Michael D’Angelica William R Jarnagin Ronald P DeMatteo Lawrence H Schwartz Scott Tuorto Leslie H Blumgart Yuman Fong | 2003 | Journal of Gastrointestinal Surgery2003,,3: | 2 |
| 8 | 经验证的多基因风险评分对中青年人冠状动脉粥样硬化性心脏病长期风险的预测作用显示文摘本文旨在了解先前获得的多基因风险评分(polygenic risk scores, PRS)对冠状动脉粥样硬化性心脏病(冠心病)长期风险的预测效用及其超越传统危险因素的附加价值,为预防策略提供信息。方法:纳入Framingham后代研究(Framingham offspring study, FOS)和社区动脉粥样硬化风险(atherosclerosis risk in communities, ARIC)研究中年龄20~59岁无冠心病的成年人数据进行分析。 | Khan SS Page C Wojdyla DM Schwartz YY Greenland P Pencina MJ 刘青(译) 郑武洪(审校) | 2022 | 中华高血压杂志2022,30,12: | 2 |
| 9 | Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma显示文摘 | Mulayim N Foster Silver D Schwartz P E | 2004 | Gynecol Oncol2004,93,3: | 2 |
| 10 | Isolation and characterization of neural progenitor cells from post-mortem human cortex显示文摘 | SCHWARTZ P H BRYANT P J FUJA T J | 2003 | J Neurosci Res2003,74,6: | 1 |
| 11 | Lead-induced anemia: doseresponse relationships and evidence for a threshold 显示文摘 | Schwartz J Landrigan P J Baker E L | 1990 | American Journal Public Health1990,80,: | 1 |
| 12 | Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation显示文摘 | Cass D Schwartz B | 2002 | N Engl J Med2002,346,12: | 1 |
| 13 | Genetic variants of platelet glycoprotein receptors and risk of stroke in young women 显示文摘 | Reiner A P Kumar P M Schwartz S M | 2000 | Stroke2000,31,7: | 1 |
| 14 | 13C andl5N natural abundance of the soil microbial biomass显示文摘 | Dijkstra P Ishizu A Doucett R Hart S C Schwartz E Menyailo O V Hungate B A | 2006 | Soil Biology & Biochemistry2006,38,: | 1 |
| 15 | Severe status asthmaticus:management with permissive hypercapnia and inhalation anesthesia显示文摘 | Mutlu GM Factor P Schwartz DE | 2002 | Crit Care Med2002,30,2: | 1 |
| 16 | Ruboxistaurin mesilate hydrate for diabetic retinopathy 显示文摘 | Schwartz S G Flynn H W Aiello L P | 2009 | Drugs Today2009,45,4: | 1 |
| 17 | A mutant form of maltose-binding protein of Escherichia coli deficient in its interaction with the bacteriophage lambda receptor protein显示文摘 | Bavoil P Wandersman C Schwartz M | 1983 | Bacteriology1983,155,: | 1 |
| 18 | Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome:A worldwide report显示文摘 | SCHWARTZ P J LOCATI E H MOSS A J | 1991 | Circulation1991,84,2: | 1 |
| 19 | Alternate estrogen re- ceptors promote invasion of inflammatory breast cancer cells via non- genomic signaling显示文摘 | Ohshiro K Schwartz A M Levine P H | 2012 | PLoS One2012,7,30: | 1 |
| 20 | Gaous pollutants inparticu- late matter epidemiology: Confounders or surrogates? 显示文摘 | Samat JA Schwartz J Cahalano P J | 2001 | Environ Health Perspect2001,109,10: | 1 |